trial

Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia

NCTId NCT00694889
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1, Phase 2 · Completed
Enrollment 144 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2015-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1, Phase 2
Status
Completed
Enrollment
144 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2007-08
Primary completion
2015-02
Eligibility
ALL · 12 Years · 35 Years

Interventions & indications

Drugs
Neuroadaptive cognitive trainingcomputer games

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
Stanley Medical Research InstituteCollaborator

Investigators

3
Sophia Vinogradov, MDPrincipal Investigator
Rachel Loewy, PhDStudy Director
Cameron S Carter, MDStudy Director

Sites

2 total
Sacramento, United StatesSan Francisco, United States

Linked catalysts

1
Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in R — primary completion2015-02

Facts & assertions

4 sourced
Enrollment
144
Phase
PHASE1,PHASE2
Primary Completion Date
2015-02
Status
COMPLETED
relationships
The graph out of here
drug
Neuroadaptive cognitive training
drug
computer games
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
Stanley Medical Research Institute
company
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Sophia Vinogradov, MD
person
Rachel Loewy, PhD
person
Cameron S Carter, MD
person